We provide you with 20 years of free, institutional-grade data for PTCT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PTCT. Explore the full financial landscape of PTCT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$10,346,387
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Almstead Neil Gregory | Sale | -8,130 | $85.23 | $692,920 | 2026-06-30 |
| Almstead Neil Gregory | Derivatives Exercise | 8,130 | 2026-06-30 | ||
| Almstead Neil Gregory | Sale | -26,283 | $85.01 | $2,234,318 | 2026-06-26 |
| Almstead Neil Gregory | Derivatives Exercise | 26,283 | 2026-06-26 | ||
| Almstead Neil Gregory | Sale | -23,749 | $80.61 | $1,914,407 | 2026-06-24 |
| Almstead Neil Gregory | Derivatives Exercise | 23,749 | 2026-06-24 | ||
| Utter Christine Marie | Sale | -19,686 | $75.56 | $1,487,474 | 2026-06-22 |
| Utter Christine Marie | Derivatives Exercise | 19,686 | 2026-06-22 | ||
| Boulding Mark Elliott | Sale | -10,462 | $78.5 | $821,267 | 2026-06-22 |
| Boulding Mark Elliott | Derivatives Exercise | 10,522 | 2026-06-22 | ||
| Pauwels Eric | Derivatives Exercise | 17,566 | 2026-06-12 | ||
| Pauwels Eric | Sale | -21,277 | $75 | $1,595,775 | 2026-06-12 |
| Boulding Mark Elliott | Sale | -2,812 | $72.08 | $202,689 | 2026-05-19 |
| Boulding Mark Elliott | Derivatives Exercise | 2,812 | 2026-05-19 | ||
| Klein Matthew B. | Sale | -12,572 | $73.06 | $918,510 | 2026-05-15 |
| Klein Matthew B. | Grant, award...etc | 12,500 | 2026-05-15 | ||
| Boulding Mark Elliott | Sale | -3,540 | $78.23 | $276,934 | 2026-05-12 |
| Boulding Mark Elliott | Derivatives Exercise | 3,540 | 2026-05-12 | ||
| Klein Matthew B. | Sale | -2,850 | $70.91 | $202,094 | 2026-04-23 |
| Boulding Mark Elliott | Sale | -2,265 | $68.91 | $156,081 | 2026-04-08 |
| Boulding Mark Elliott | Derivatives Exercise | 2,265 | 2026-04-08 | ||
| Golden Lee Scott | Sale | -829 | $67.99 | $56,364 | 2026-04-06 |
| Almstead Neil Gregory | Sale | -52,003 | $68.89 | $3,582,487 | 2026-04-03 |
| Chutter Jessica Caroline | Grant, award...etc | 7,333 | 2026-03-26 | ||
| Klein Matthew B. | Sale | -2,662 | $64.08 | $170,581 | 2026-03-13 |
| Klein Matthew B. | Grant, award...etc | 12,500 | 2026-03-13 | ||
| Okey Stephanie | Sale | -15,167 | $70 | $1,061,690 | 2026-03-12 |
| Okey Stephanie | Derivatives Exercise | 15,167 | 2026-03-12 | ||
| Okey Stephanie | Sale | -6,333 | $63.38 | $401,386 | 2026-03-09 |
| Golden Lee Scott | Sale | -10,000 | $63.38 | $633,800 | 2026-03-09 |
| Almstead Neil Gregory | Sale | -3,989 | $63.38 | $252,823 | 2026-03-09 |
| Boulding Mark Elliott | Sale | -3,019 | $68.54 | $206,922 | 2026-02-23 |
| Utter Christine Marie | Sale | -2,494 | $69.36 | $172,984 | 2026-02-20 |
| Pauwels Eric | Sale | -20,508 | $75.66 | $1,551,635 | 2025-12-23 |
| Pauwels Eric | Derivatives Exercise | 20,508 | 2025-12-23 | ||
| Pauwels Eric | Sale | -43,492 | $75.28 | $3,274,078 | 2025-12-19 |
| Pauwels Eric | Derivatives Exercise | 43,492 | 2025-12-19 | ||
| SCHMERTZLER MICHAEL | Derivatives Exercise | 24,000 | 2025-12-18 | ||
| Reeve Emma | Sale | -733 | $78.62 | $57,628 | 2025-12-05 |
| Reeve Emma | Derivatives Exercise | 733 | 2025-12-05 | ||
| Klein Matthew B. | Sale | -3,428 | $79.07 | $271,052 | 2025-12-03 |
| Klein Matthew B. | Grant, award...etc | 15,625 | 2025-12-03 | ||
| Jacobson Allan Steven | Sale | -26,000 | $80.13 | $2,083,380 | 2025-11-26 |
| Jacobson Allan Steven | Derivatives Exercise | 26,000 | 2025-11-26 | ||
| Almstead Neil Gregory | Sale | -107,500 | $82.63 | $8,882,725 | 2025-11-26 |
| Almstead Neil Gregory | Derivatives Exercise | 107,500 | 2025-11-26 | ||
| Reeve Emma | Sale | -10,000 | $79.5 | $795,000 | 2025-11-25 |
| Reeve Emma | Derivatives Exercise | 10,000 | 2025-11-25 | ||
| Boulding Mark Elliott | Sale | -2,812 | $75.64 | $212,700 | 2025-11-19 |
| Boulding Mark Elliott | Derivatives Exercise | 2,812 | 2025-11-19 | ||
| Reeve Emma | Sale | -7,333 | $74.5 | $546,309 | 2025-11-14 |
| Reeve Emma | Derivatives Exercise | 7,333 | 2025-11-14 | ||
| Reeve Emma | Derivatives Exercise | 12,000 | 2025-10-31 | ||
| Reeve Emma | Sale | -15,666 | $69.5 | $1,088,787 | 2025-10-31 |
| Boulding Mark Elliott | Sale | -3,375 | $62.89 | $212,254 | 2025-10-09 |
| Boulding Mark Elliott | Derivatives Exercise | 3,375 | 2025-10-09 | ||
| Almstead Neil Gregory | Sale | -55,000 | $65.46 | $3,600,300 | 2025-10-07 |
| Almstead Neil Gregory | Derivatives Exercise | 55,000 | 2025-10-07 | ||
| Boulding Mark Elliott | Sale | -24,921 | $64.43 | $1,605,660 | 2025-10-07 |
| Boulding Mark Elliott | Derivatives Exercise | 24,921 | 2025-10-07 | ||
| Reeve Emma | Sale | -25,562 | $65.09 | $1,663,831 | 2025-10-07 |
| Reeve Emma | Derivatives Exercise | 25,562 | 2025-10-07 | ||
| Jacobson Allan Steven | Sale | -12,000 | $65 | $780,000 | 2025-10-07 |
| Jacobson Allan Steven | Derivatives Exercise | 12,000 | 2025-10-07 | ||
| Reeve Emma | Derivatives Exercise | 10,837 | 2025-09-16 | ||
| Reeve Emma | Sale | -15,705 | $59.5 | $934,448 | 2025-09-16 |
| Boulding Mark Elliott | Sale | -47,249 | $61 | $2,882,189 | 2025-09-15 |
| Boulding Mark Elliott | Derivatives Exercise | 47,249 | 2025-09-15 | ||
| SOUTHWELL DAVID P | Sale | -12,000 | $58.34 | $700,080 | 2025-09-11 |
| SOUTHWELL DAVID P | Derivatives Exercise | 12,000 | 2025-09-11 | ||
| Pauwels Eric | Sale | -39,850 | $56.94 | $2,269,059 | 2025-09-09 |
| Pauwels Eric | Derivatives Exercise | 39,850 | 2025-09-09 | ||
| Jacobson Allan Steven | Sale | -1,667 | $50.15 | $83,600 | 2025-09-02 |
| Boulding Mark Elliott | Sale | -2,813 | $48.58 | $136,656 | 2025-08-19 |
| Boulding Mark Elliott | Derivatives Exercise | 2,813 | 2025-08-19 | ||
| Klein Matthew B. | Sale | -10,739 | $51.74 | $555,636 | 2025-08-05 |
| Klein Matthew B. | Grant, award...etc | 75,000 | 2025-08-05 | ||
| Gravier Pierre | Sale | -2,516 | $49.46 | $124,441 | 2025-07-17 |
| Boulding Mark Elliott | Sale | -2,812 | $46.18 | $129,858 | 2025-05-19 |
| Boulding Mark Elliott | Derivatives Exercise | 2,812 | 2025-05-19 | ||
| Klein Matthew B. | Sale | -2,804 | $48.74 | $136,656 | 2025-04-24 |
The information provided in this report about PTCT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
PTC Therapeutics, Inc(NASDAQ:PTCT) 
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for the treatment of rare disorders. The company offers Translarna (ataluren) and Emflaza (deflazacort) for the treatment of nonsense mutation Duchenne muscular dystrophy in...
Website: http://www.ptcbio.com
Founded: 1998
Full Time Employees: 754
Sector: Healthcare
Industry: Biotechnology